Local, Sustained, and Targeted Co-Delivery of MEK Inhibitor and Doxorubicin Inhibits Tumor Progression in E-Cadherin-Positive Breast Cancer
Article in Pharmaceutics (July 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Pharmaceutics (July 2024)
Article in Frontiers in Immunology (May 2024)
Article in International Journal of Molecular Sciences (May 2024)